Migraine treatment

View All

Migraine-Market Analysis
Migraine Market: How Pharma Companies are trying to Uncomplicate the Disease and Bring in Novel Therapies

Migraine is a medical condition characterized by recurrent headaches that can last from 4 to 72 hours and often results in a wide range of symptoms. It is mainly associated with a painful headache, however, the affected person may experience nausea, vomiting, disturbed vision, sensitivity to light, sound, and smell...

Find More

Migraine Treatment
A New Era for Migraine Treatment and CGRP antibodies

The World Health Organization’s disability rating for migraine ranks it as the 19th most common reason for disability. According to the Migraine Trust Organization, Migraine is ranked as the 7th most disabling disease in the world (a cause for a loss of 2.9% of all years of life lost to disability/YLDs). The ...

Find More